Funding Reflects Confidence in RTS Market

A Series A financing round that raised €3 million ($3.2M) will boost the product development roadmap for ABC Transfer, a new manufacturer of secure Rapid Transfer Systems (RTS) for the biopharmaceutical industry. Led by Go Capital, a representative of the Loire Valley Invest Fund, the French National Bank Bpifrance and the regional government of Centre-Val de Loire, the funding reflects investor confidence both in the company’s business model and in potential market opportunities in aseptic transfer systems.  

Following collaborative input from nine GMP industrial partners, the ABC Transfer® system, was designed from scratch to resolve 50 shortcomings identifies in currently available RTP and RTS solutions. The company will also strengthen its R&D activities, maintaining a budget of at least 15% of its turn-over over the long term.

Thanking the investors, Thierry Girard, CEO of ABC Transfer said: “Achieving this strong financial backing means that we will be able to roll out a complete range of Rapid Transfer System solutions, eagerly awaited by customers and position our products as true innovations within biopharmaceuticals. The benefits of our high-performance and ergonomic designs include ultra-cleanliness, GMP compliance, safety and security. We look forward to raising awareness with customers of these and a host of revolutionary RTS system features.”

“Go Capital is proud to accompany ABC Transfer’s management team on this project. It is set to become one of the major manufacturers of equipment and consumables for aseptic transfer chains, thanks to its significant breakthrough in innovation and large portfolio of patents," said Herve Bachelot-Lallier, investment director of Go Capital. “The rich experience of the team, the dynamics of the sector and the need for quality in the pharmaceutical industry are assets favourable to ABC Transfer’s success.’’

ABC Transfer was co-founded in June 2019 by Thierry Girard, CEO, CFO and CCO and Jean-Luc Schneider, COO and CTO.